Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milrinone versus standard management for enterovirus 71-induced pulmonary edema or neurogenic shock in children
ISRCTN76926623Phase 3Completed
- Sponsor
- National Health Research Institutes
- Start
- Jun 2007
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of milrinone in enterovirus 71 infection and Brainstem encephalitis (BE) (2 arms), sponsored by National Health Research Institutes. Primary endpoints: 1-week mortality and Hospital outcome follow-up. Started Jun 2007; status: completed.
02
Drugs
milrinone
03
Conditions
enterovirus 71 infectionBrainstem encephalitis (BE)
Beyond the preview
Go deeper on ISRCTN76926623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN76926623.